| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $6K | — | — |
| SG&A Expense | $32K | +85.6% | — |
| Operating Income | -$32K | -85.6% | — |
| Net Income | -$32K | -85.6% | — |
| EPS (Basic) | $0.01 | — | — |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $890 | +709.1% | — |
| Current Assets | $36K | — | — |
| Total Assets | $231K | +11.5% | — |
| Current Liabilities | $256K | +7.0% | — |
| Total Liabilities | $256K | +7.0% | — |
| Stockholders' Equity | -$25K | +22.2% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$69K | -384.5% | — |
| Investing Cash Flow | -$17K | +0.0% | — |
| Financing Cash Flow | $84K | +193.4% | — |